Table 2 Clinical and mycological evaluation of the antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
From: Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
Control group versus treatment group | |||
|---|---|---|---|
Rat/number | FG scoring | ||
Liver | Spleen | Kidneys | |
Control | |||
1 | 1 | 0 | 1 |
2 | 1 | 1 | 1 |
3 | 1 | 0 | 1 |
4 | 1 | 1 | 0 |
5 | 1 | 1 | 0 |
6 | 1 | 0 | 0 |
PO | |||
1 | 0 | 1 | 0 |
2 | 0 | 1 | 0 |
3 | 0 | 0 | 0 |
4 | 1 | 0 | 0 |
5 | 1 | 0 | 0 |
6 | 1 | 0 | 0 |
AMB | |||
1 | 0 | 0 | 0 |
2 | 1 | 0 | 0 |
3 | 0 | 0 | 0 |
4 | 1 | 1 | 0 |
5 | 0 | 0 | 0 |
6 | 1 | 0 | 0 |